您的位置: 首页 > 农业专利 > 详情页

MITOCHONDRIA-TARGETING PLATINUM(IV) PRODRUG
专利权人:
University of Georgia Research Foundation; Inc.
发明人:
DHAR, Shanta,PATHAK, Rakesh,MARRACHE, Sean
申请号:
EP15776882
公开号:
EP3129017A4
申请日:
2015.04.08
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Pt(IV) compounds include a mitochondria targeting moiety. One example of a Pt(IV) compound having a mitochondria targeting moiety is a Pt(IV) cisplatin-based compound. Upon reduction, the mitochondrial targeting moieties are released resulting in a Pt(II) therapeutic agent. Pt(IV) compounds including a mitochondria targeting moiety can be included in nanoparticles. The compounds or nanoparticles can be used to treat, for example, cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充